University of Turin-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2021

  1. Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

    Leukemia, Vol. 35, Núm. 5, pp. 1344-1355

2020

  1. Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors

    Leukemia, Vol. 34, Núm. 6, pp. 1495-1502

2018

  1. Considerations for Treatment-free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient–Physician Perspective

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 18, Núm. 6, pp. 375-379

  2. Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

    Journal of Cancer Research and Clinical Oncology, Vol. 144, Núm. 5, pp. 945-954

2017

  1. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the ENESTfreedom study

    Leukemia, Vol. 31, Núm. 7, pp. 1525-1531